Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luma Womb is a private Paris-based femtech/medical device company developing a patented intrauterine photobiomodulation device for infertility associated with thin endometrium. The company positions its technology as a non-chemical, low-level light therapy intended to regenerate the endometrial lining and improve uterine receptivity for embryo implantation. Luma Womb appears to be focused on a single lead product rather than a broad therapeutics pipeline, and has been associated with startup and accelerator programs including Tech4Eva. Publicly available information suggests the company is an early-stage, privately held medtech venture rather than a clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luma Womb.